These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 26143174)

  • 21. Body Mass Index and Platelet Reactivity During Dual Antiplatelet Therapy With Clopidogrel or Ticagrelor.
    Nardin M; Verdoia M; Sartori C; Pergolini P; Rolla R; Barbieri L; Schaffer A; Marino P; Bellomo G; Suryapranata H; De Luca G;
    J Cardiovasc Pharmacol; 2015 Oct; 66(4):364-70. PubMed ID: 26065844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coronary stent management in elective genitourinary surgery.
    Gupta AD; Streiff M; Resar J; Schoenberg M
    BJU Int; 2012 Aug; 110(4):480-4. PubMed ID: 22192977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet-Mediated Thrombosis: From Bench to Bedside.
    Gurbel PA; Jeong YH; Navarese EP; Tantry US
    Circ Res; 2016 Apr; 118(9):1380-91. PubMed ID: 27126648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Response variability to P2Y12 receptor inhibitors: expectations and reality.
    Siller-Matula JM; Trenk D; Schrör K; Gawaz M; Kristensen SD; Storey RF; Huber K;
    JACC Cardiovasc Interv; 2013 Nov; 6(11):1111-28. PubMed ID: 24262612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of bleeding risk of interventional techniques: a best evidence synthesis of practice patterns and perioperative management of anticoagulant and antithrombotic therapy.
    Manchikanti L; Falco FJ; Benyamin RM; Caraway DL; Kaye AD; Helm S; Wargo BW; Hansen H; Parr AT; Singh V; Swicegood JR; Smith HS; Schultz DM; Malla Y; Hirsch JA
    Pain Physician; 2013 Apr; 16(2 Suppl):SE261-318. PubMed ID: 23615893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A therapeutic window for platelet reactivity for patients undergoing elective percutaneous coronary intervention: results of the ARMYDA-PROVE (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity for Outcome Validation Effort) study.
    Mangiacapra F; Patti G; Barbato E; Peace AJ; Ricottini E; Vizzi V; Gatto L; D'Ambrosio A; De Bruyne B; Wijns W; Di Sciascio G
    JACC Cardiovasc Interv; 2012 Mar; 5(3):281-9. PubMed ID: 22440493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does Platelet Reactivity Predict Bleeding in Patients Needing Urgent Coronary Artery Bypass Grafting During Dual Antiplatelet Therapy?
    Mahla E; Prueller F; Farzi S; Pregartner G; Raggam RB; Beran E; Toller W; Berghold A; Tantry US; Gurbel PA
    Ann Thorac Surg; 2016 Dec; 102(6):2010-2017. PubMed ID: 27378554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiplatelet therapy and outcome in patients undergoing surgery following coronary stenting: Results of the surgery after stenting registry.
    Rossini R; Angiolillo DJ; Musumeci G; Capodanno D; Lettino M; Trabattoni D; Pilleri A; Calabria P; Colombo P; Bernabò P; Ferlini M; Ferri M; Tarantini G; De Servi S; Savonitto S
    Catheter Cardiovasc Interv; 2017 Jan; 89(1):E13-E25. PubMed ID: 27404797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence and outcome of surgical procedures after coronary bare-metal and drug-eluting stent implantation: a report from the CREDO-Kyoto PCI/CABG registry cohort-2.
    Tokushige A; Shiomi H; Morimoto T; Furukawa Y; Nakagawa Y; Kadota K; Iwabuchi M; Shizuta S; Tada T; Tazaki J; Kato Y; Hayano M; Abe M; Ehara N; Inada T; Kaburagi S; Hamasaki S; Tei C; Nakashima H; Ogawa H; Tatami R; Suwa S; Takizawa A; Nohara R; Fujiwara H; Mitsudo K; Nobuyoshi M; Kita T; Kimura T;
    Circ Cardiovasc Interv; 2012 Apr; 5(2):237-46. PubMed ID: 22396582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preoperative management of antiplatelet drugs for a coronary artery stent: how can we hit a moving target?
    Vetter TR; Hunter JM; Boudreaux AM
    BMC Anesthesiol; 2014; 14():73. PubMed ID: 25183953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of antiplatelet effects of a modified protocol by platelet aggregation in patients undergoing "one-stop" hybrid coronary revascularization.
    Gao P; Xiong H; Zheng Z; Li L; Gao R; Hu SS
    Platelets; 2010; 21(3):183-90. PubMed ID: 20201634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of Different β-Blockers on Platelet Aggregation in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy.
    Ignjatovic V; Pavlovic S; Miloradovic V; Andjelkovic N; Davidovic G; Djurdjevic P; Stolic R; Iric-Cupic V; Simic I; Ignjatovic VD; Petrovic N; Smiljanic Z; Zdravkovic V; Simovic S; Jovanovic D; Nesic J
    J Cardiovasc Pharmacol Ther; 2016 Jan; 21(1):44-52. PubMed ID: 25868659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary intervention: is the current antiplatelet therapy adequate?
    Bliden KP; DiChiara J; Tantry US; Bassi AK; Chaganti SK; Gurbel PA
    J Am Coll Cardiol; 2007 Feb; 49(6):657-66. PubMed ID: 17291930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The future of platelet function testing to guide therapy in clopidogrel low and enhanced responders.
    Bernlochner I; Byrne RA; Kastrati A; Sibbing D
    Expert Rev Cardiovasc Ther; 2011 Aug; 9(8):999-1014. PubMed ID: 21878045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Most Recent Evidence Behind Aggregometry and Genotyping Methods as Platelet Function Testing for Tailored Anti-Platelet Treatment Among PCI Patients.
    Gajda SN; Kołtowski Ł; Tomaniak M
    Adv Clin Exp Med; 2015; 24(4):687-93. PubMed ID: 26469115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The net clinical benefit of personalized antiplatelet therapy in patients undergoing percutaneous coronary intervention.
    Siller-Matula JM; Gruber C; Francesconi M; Dechant C; Jilma B; Delle-Karth G; Grohs K; Podczeck-Schweighofer A; Christ G
    Clin Sci (Lond); 2015 Jan; 128(2):121-30. PubMed ID: 25124236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mean platelet volume and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor.
    Verdoia M; Pergolini P; Rolla R; Nardin M; Barbieri L; Schaffer A; Bellomo G; Marino P; Suryapranata H; De Luca G
    Expert Opin Pharmacother; 2015; 16(12):1739-47. PubMed ID: 26067422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet reactivity to adenosine diphosphate and long-term ischemic event occurrence following percutaneous coronary intervention: a potential antiplatelet therapeutic target.
    Gurbel PA; Antonino MJ; Bliden KP; Dichiara J; Suarez TA; Singla A; Tantry US
    Platelets; 2008 Dec; 19(8):595-604. PubMed ID: 19012177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Perioperative Cardiovascular Medication Management in Noncardiac Surgery: Common Questions.
    Mikhail MA; Mohabbat AB; Ghosh AK
    Am Fam Physician; 2017 May; 95(10):645-650. PubMed ID: 28671407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A single-centre, randomised study on platelet reactivity after abrupt or gradual discontinuation of long-term clopidogrel therapy in patients after percutaneous coronary intervention.
    Nadrowski P; Syzdół M; Wańha W; Nabiałek E; Skrzypek M; Góral J; Siewniak M; Kozakiewicz K; Ochała A; Tendera M; Wojakowski W
    Kardiol Pol; 2016; 74(7):634-43. PubMed ID: 26779855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.